The Cancer Cachexia Index Can Be Used to Prognostically Predict Patients with Gastric Cancer Undergoing Gastrectomy
Annals of Nutrition and Metabolism · 2023
DOI: 10.1159/000534244 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Annals of Nutrition and Metabolism, 2023. Verfasst von Katsunobu Sakurai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Osaka City General Hospital, Osaka, Japan. Hauptthemen laut MEDLINE: Stomach Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
Introduction
Cancer cachexia occurs in cancer patients more frequently as the cancer progresses, with a negative impact on treatment outcomes. In this study, we sought to clarify the clinical impact of a cancer cachexia index (CXI) in patients with gastric cancer (GC) undergoing gastrectomy.
Methods
Between January 2013 and December 2018, we reviewed data from 556 patients treated for GC at our hospital. CXI was calculated using skeletal muscle index (SMI), serum albumin, and neutrophil-lymphocyte ratios (NLR). Patients were divided into high (n = 414) or low CXI (n = 142) groups. We investigated the clinical impact of CXI in patients with GC undergoing gastrectomy.
Results
Multivariate analyses of 5-year overall survival (OS) and cancer-specific survival (CSS) rates indicated that a low CXI was independently associated with unfavorable outcomes for patients with GC. In multivariate analyses, SMI was independent predictor of OS but not CSS. NLR was not an independent predictor of either OS or CSS. Complication incidences (≥ Clavien Dindo 3) were non-significantly higher in the low (vs. high) CXI group.
Conclusion
CXI was a more valuable prognostic biomarker when compared with SMI or NLR in GC patients undergoing gastrectomy. We suggest that patients with low CXI values should be given more comprehensive treatment, including exercise and nutritional therapy to improve clinical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterological Surgery, Osaka City General Hospital, Osaka, Japan.
- Department of Gastroenterological Surgery, Osaka Metropolitan University, Osaka, Japan.
Zitieren
APA
Sakurai, K., Kubo, N., Hasegawa, T., Nishimura, J., Iseki, Y., Nishii, T., Inoue, T., Yashiro, M., Nishiguchi, Y., & Maeda, K. (2023). The Cancer Cachexia Index Can Be Used to Prognostically Predict Patients with Gastric Cancer Undergoing Gastrectomy. Annals of Nutrition and Metabolism. https://doi.org/10.1159/000534244
Vancouver
Sakurai K, Kubo N, Hasegawa T, Nishimura J, Iseki Y, Nishii T, et al. The Cancer Cachexia Index Can Be Used to Prognostically Predict Patients with Gastric Cancer Undergoing Gastrectomy. Annals of Nutrition and Metabolism. 2023. doi:10.1159/000534244
BibTeX
@article{Sakurai2023,
author = {Sakurai, Katsunobu and Kubo, Naoshi and Hasegawa, Tsuyoshi and Nishimura, Junya and Iseki, Yasuhito and Nishii, Takafumi and Inoue, Toru and Yashiro, Masakazu and Nishiguchi, Yukio and Maeda, Kiyoshi},
title = {The Cancer Cachexia Index Can Be Used to Prognostically Predict Patients with Gastric Cancer Undergoing Gastrectomy},
journal = {Annals of Nutrition and Metabolism},
year = {2023},
doi = {10.1159/000534244}
}
EUVIMED